The presentations of the Pre-conference courses held on Wednesday morning 21/9 will be sent directly to the registered participants. 

Training course 1: Measurable residual disease in MM: Planned to be sent out in the week of 14 November.

Training course 2: Validation and ISO accreditation of FCM assays: Planned to be sent out in the week of 14 November.

Training course 3: AML-MRD: Presentations have been emailed on 15/10. Please check your spam folder if you have not received it.

PAR01: New frontiers in MRD

• Jesse Tettero - Towards Further Harmonization on Technical Aspects of Flow Cytometry-based MRD Quantification in AML: Experience of the ELN MRD Working Party
• Jacqueline Cloos - Impact of combining molecular and flow MRD

PAR04: Innovative clinical applications

• Sebastian Böttcher - CLL MRD
• Cirino Botta - Using flow cytometry data to unravel disease outcome

PAR07: Tissue Flow Cytometry

• Hao-Wei Wang - On KSHV (HHV8)-associated lymphoproliferation 
• Elaine Sobral da Costa - Standardized panel and procedures for pediatric solid tumors diagnostic by
  flow cytometry

PAR10: Immune monitoring in haematological malignancies 

• Hao-Wei Wang - Flow cytometry in CAR-T therapy 
• Diede van Ens - presentation not available

PAR13: Multiomics and Artificial intelligence

• Andrew Filby - What can the single cell “fossil record” of COVID19 lung tell us about potential therapeutic intervention?
• Wolfgang Kern - Application of artificial intelligence models to flow cytometric data for diagnosing hematologic neoplasms

PAR02: Flow for Newbies - Intro to basics and pitfalls

• Claudio Ortolani -  Flow Cytometry in clinical practice: a sociological point of view Presenter has not authorised publication
• Tomas Kalina - Diagnostic antibodies: CD Nomenclature and beyond

PAR05: Lab do’s & don'ts

• Jeroen te Marvelde - Which competency does a flow cytometrist need?
• Cristina Teodosio - Telling fluorescence apart

PAR08: A practical approach to IVDR

• Elizabeth Macintyre - Present status of the IVDR regulation
• Isabel Dombrink - Preparing for IVDR in the clinical lab

PAR 11: Validations in Cytometry

• Iuri Marinov - Assay validation in the era of ISO 15189 and CLSI H62
• Ulrika Johansson - Assay validation: Practical examples

PAR14: On Data Integrity

• Enrique O'Connor - Pre-Clinical Data Quality Presentation not available, data have not yet been published 
• Jordi Petriz - Data interpretation

• PAR03: Antigen-Specific Immunity - T-cells/infectious antigens
• Eva Piano Mortari - The immune tumor microenvironment in the context of checkpoint inhibitor treatment
• Gijsbert van Nierop - Original antigenic sin in SARS-CoV-2

PAR06: Immune System Ageing

• IIoakim Spyridopolous - presentation not available
• Birgit Weinberger - Vaccines for older adults: Challenges and Developments

PAR09: Trained immunity

• Robin Choudhury - Hyperglycemia Induces Trained Immunity in Macrophages and Their Precursors and Promotes Atherosclerosis
• Timo Rückert - Clonal expansion and epigenetic inheritance shape long-lasting NK cell memory

PAR12: Immunity in neurological disease

• Paulus Rommer - What we have learned from the Corona pandemic: Vaccination in immunocompromised patients
• Denise Fitzgerald - Protective and Regenerative Roles of T Cells in Central Nervous System Disorders Presenter has not authorised publication

PAR15: Fringe Applications

• Alfonso Blanco - Studying some very small events
• Ken Nally - Using flow to investigate Microbiome Biology